The SST/CORT system seems therefore to stand at the regulatory crossroads between tumor development and deregulated metabolic conditions, where it could play a singular role in the pathological interaction between obesity and breast cancer, an endocrine-related pathological condition profoundly influenced by the metabolic status [25, 26]. The gene discussed is CORT; the disease is breast carcinoma.